TNDM Q4 2024 Earnings — Tandem Diabetes Care, Inc. Revenue & Financial Results | Market Cap Arena

TNDMTandem Diabetes Care, Inc.

$1B

Q4 2024 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$283M+43.6% YoY

Gross Profit

$157M55.7% margin

Operating Income

-$582,000-0.2% margin

Net Income

$755,0000.3% margin

EPS (Diluted)

$0.01

QoQ Revenue Growth

-22.2%

Cash Flow

Operating Cash Flow

$11M

Free Cash Flow

$8M

Stock-Based Comp.

$28M

Balance Sheet

Total Assets

$968M

Total Liabilities

$705M

Stockholders' Equity

$263M

Cash & Equivalents

$69M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$283M	$197M	+43.6%
Gross Profit	$157M	$93M	+68.8%
Operating Income	-$582,000	-$35M	+98.3%
Net Income	$755,000	-$30M	+102.5%

Geographic Segments

UNITED STATES

$215M76%

Non-US

$68M24%